Diagnostic Testing & Technology Report

The Riverside Company (Cleveland and New York City), a global private equity firm focused on the smaller end of the middle market (companies valued up to $200 million), has acquired GTI Diagnostics (Waukesha, Wis.), which develops, manufactures, and markets in vitro diagnostic assays for the transplantation (HLA), blood bank, and coagulation laboratory markets. GTI’s more than 20 test kits are used by approximately 400 labs around the world. Financial terms of the deal were not disclosed.